Surexpression de HER2 : un dictat?
-
Published:2012
Issue:
Volume:
Page:168-173
-
ISSN:
-
Container-title:Cancer du sein : surdiagnostic, surtraitement
-
language:
-
Short-container-title:
Reference16 articles.
1. Beaton GT (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 148: 162–165
2. Wolff AC, Dowsett M (2011) Estrogen receptor: a never ending story? J Clin Oncol 29: 2955–2958
3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182
4. Slamon DJ, Godolphin W, Jones LA et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712
5. Slamon DJ, Leyland-Jones B, Shak S et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783–792